Trial intelligence / Profile preview

Hyperbaric oxygen therapy for long-term gastrointestinal adverse effects after pelvic radiotherapy

2008-002152-26Phase 3Completed

Sponsor
Royal Marsden NHS Foundation Trust
Start
Jun 2008
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of oxygen gas in gastrointestinal conditions and pelvic malignancies (2 arms), sponsored by Royal Marsden NHS Foundation Trust. Started Jun 2008; status: completed.

02

Drugs

oxygen gas
03

Conditions

gastrointestinal conditionspelvic malignancies

Beyond the preview

Go deeper on 2008-002152-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002152-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call